Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,241 | 90 | 84.2% |
| Travel and Lodging | $419.20 | 1 | 15.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Inari Medical, Inc. | $677.68 | 3 | $0 (2024) |
| W. L. Gore & Associates, Inc. | $247.52 | 3 | $0 (2024) |
| Novo Nordisk Inc | $212.35 | 10 | $0 (2024) |
| Lundbeck LLC | $152.73 | 8 | $0 (2024) |
| ABBVIE INC. | $151.53 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $143.49 | 8 | $0 (2024) |
| GlaxoSmithKline, LLC. | $132.31 | 6 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $113.08 | 7 | $0 (2024) |
| Lilly USA, LLC | $90.64 | 4 | $0 (2023) |
| ARGON MEDICAL DEVICES, INC. | $76.86 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $912.71 | 31 | Inari Medical, Inc. ($198.48) |
| 2023 | $1,151 | 27 | Inari Medical, Inc. ($479.20) |
| 2022 | $193.18 | 9 | GlaxoSmithKline, LLC. ($66.38) |
| 2021 | $293.73 | 18 | Otsuka America Pharmaceutical, Inc. ($79.08) |
| 2020 | $110.06 | 6 | Eisai Inc. ($36.31) |
All Payment Transactions
91 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.91 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/05/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Lithoplasty | ||||||
| 09/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.26 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $0.32 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.68 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2024 | W. L. Gore & Associates, Inc. | GORE ENFORM Preperitoneal Biomaterial (Device) | Food and Beverage | In-kind items and services | $100.72 | General |
| Category: Devices | ||||||
| 09/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.47 | General |
| Category: PSYCHIATRY | ||||||
| 08/26/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.29 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 07/30/2024 | ARGON MEDICAL DEVICES, INC. | Clot Management (Device) | Food and Beverage | Cash or cash equivalent | $47.88 | General |
| Category: VASCULAR | ||||||
| 07/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Respiratory | ||||||
| 06/27/2024 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $198.48 | General |
| Category: VTE | ||||||
| 06/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Insomnia | ||||||
| 06/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $27.48 | General |
| Category: PSYCHIATRY | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: NEUROSCIENCE | ||||||
| 04/20/2024 | ARGON MEDICAL DEVICES, INC. | Clot Management (Device) | Food and Beverage | Cash or cash equivalent | $28.98 | General |
| Category: VASCULAR | ||||||
| 04/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $29.32 | General |
| Category: PSYCHIATRY | ||||||
| 04/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 297 | 499 | $80,861 | $41,551 |
| 2022 | 8 | 517 | 848 | $115,619 | $67,866 |
| 2021 | 7 | 463 | 776 | $98,970 | $63,165 |
| 2020 | 5 | 670 | 1,662 | $279,013 | $132,869 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 67 | 211 | $20,490 | $13,209 | 64.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 94 | 107 | $14,115 | $10,077 | 71.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 52 | 54 | $13,770 | $7,410 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 71 | $20,732 | $5,939 | 28.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $3,278 | $1,383 | 42.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $2,100 | $1,343 | 63.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 21 | $2,240 | $1,335 | 59.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,136 | $855.48 | 20.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 137 | 414 | $37,260 | $23,440 | 62.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 167 | 196 | $24,500 | $15,928 | 65.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 94 | 98 | $24,990 | $15,455 | 61.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 31 | $9,052 | $3,144 | 34.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 53 | 53 | $5,565 | $3,015 | 54.2% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $4,500 | $2,571 | 57.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 19 | 21 | $3,360 | $2,252 | 67.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $6,392 | $2,062 | 32.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 141 | 430 | $38,700 | $24,828 | 64.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 105 | 111 | $28,305 | $17,860 | 63.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 139 | 157 | $19,625 | $13,020 | 66.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 23 | 23 | $5,750 | $3,360 | 58.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 30 | 30 | $3,150 | $1,730 | 54.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $1,760 | $1,205 | 68.5% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 14 | 14 | $1,680 | $1,161 | 69.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 243 | 1,094 | $142,438 | $63,879 | 44.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 211 | 241 | $83,535 | $39,675 | 47.5% |
About Dr. Smeet Patel, MD
Dr. Smeet Patel, MD is a Internal Medicine healthcare provider based in Largo, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1558758987.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Smeet Patel, MD has received a total of $2,661 in payments from pharmaceutical and medical device companies, with $912.71 received in 2024. These payments were reported across 91 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($2,241).
As a Medicare-enrolled provider, Patel has provided services to 1,947 Medicare beneficiaries, totaling 3,785 services with total Medicare billing of $305,451. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Largo, FL
- Active Since 04/23/2015
- Last Updated 03/14/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1558758987
Products in Payments
- CT THROMBECTOMY SYSTEM KIT (Device) $419.20
- REXULTI (Drug) $265.81
- FLOWTRIEVER CATHETER, S (Device) $258.48
- VRAYLAR (Drug) $151.53
- TRELEGY ELLIPTA (Drug) $132.31
- Ozempic (Drug) $126.47
- GORE TAG Conformable Thoracic Stent Graft (Device) $105.13
- GORE ENFORM Preperitoneal Biomaterial (Device) $100.72
- Clot Management (Device) $76.86
- MOUNJARO (Drug) $75.42
- HETLIOZ (Drug) $75.36
- Dexcom G6 Transmitter (Medical Supply) $69.64
- AUSTEDO (Drug) $56.13
- AIRSUPRA (Drug) $54.95
- FARXIGA (Drug) $54.36
- CAPLYTA (Drug) $49.85
- INGREZZA (Drug) $49.21
- QUVIVIQ (Drug) $48.14
- Wegovy (Drug) $43.22
- EXCLUDER Conformable AAA Endoprosthesis with Active Control (Device) $41.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Largo
Dr. Brian Lake, D.o, D.O
Internal Medicine — Payments: $1.1M
Dr. Eduardo Martinez, Md, MD
Internal Medicine — Payments: $19,139
Rakhee Shah, D.o, D.O
Internal Medicine — Payments: $18,119
Randal Worth, Do, DO
Internal Medicine — Payments: $15,659
Vlad Badescu, Md, MD
Internal Medicine — Payments: $14,612
Jennifer Kudelko, D.o, D.O
Internal Medicine — Payments: $14,033